Relief for foreign firms amid reports of new Indian pricing panel
This article was originally published in SRA
Executive Summary
India is reported to have put in place a new panel to finalize a mechanism for price negotiations for patented drugs – an issue that's been under deliberation for more than six years now. The establishment of the panel is expected to be welcome by foreign firms.